Gastrointestinal Mucosal Immunology and Mechanisms of Inflammation

Pediatric Gastrointestinal and Liver Disease

Volumn , Issue , 2011, Pages 50-63

  Murch, Simon ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882835888     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0774-8.10006-5     Document Type: Chapter

References (149)

1. Turner J.R. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009, 9:799-809.
2. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
3. Duerkop B.A., Vaishnava S., Hooper L.V. Immune responses to the microbiota at the intestinal mucosal surface. Immunity 2009, 31:368-376.
4. Brandtzaeg P., Johansen F- E. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 2005, 206:32-63.
5. Spencer J., Barone F., Dunn-Walters D. Generation of Immunoglobulin diversity in human gut-associated lymphoid tissue. Semin Immunol 2009, 21:139-146.
6. Neurath M.F., Finotto S., Glimcher L.H. The role of Th1/Th2 polarization in mucosal immunity. Nat Med 2002, 8:567-573.
7. van Wijk F., Cheroutre H. Intestinal T cells: facing the mucosal immune dilemma with synergy and diversity. Semin Immunol 2009, 21:130-138.
8. Wershil B.K., Furuta G.T. 4. Gastrointestinal mucosal immunity. J Allergy Clin Immunol 2008, 121:S380-S383.
9. Coombes J.L., Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008, 8:435-446.
10. Shale M., Ghosh S. How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease. Gut 2009, 58:1291-1299.
11. Keshav S. Paneth cells: leukocyte-like mediators of innate immunity in the intestine. J Leukoc Biol 2006, 80:500-508.
12. Salzman N.H., Hung K., Haribhai D., et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010, 11:76-83.
13. Klionsky D.J. Crohn's disease, autophagy, and the Paneth cell. N Engl J Med 2009, 360:1785-1786.
14. Hermiston M.L., Gordon J.I. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995, 270:1203-1207.
15. Atisook K., Madara J.L. An oligopeptide permeates intestinal tight junctions at glucose-elicited dilatations. Implications for oligopeptide absorption. Gastroenterology 1991, 100:719-724.
16. Salvestrini C., McGrath J.A., Ozoemena L., et al. Desquamative enteropathy and pyloric atresia without skin disease caused by a novel intracellular β4 integrin mutation. J Pediatr Gastroenterol Nutr 2008, 47:585-591.
17. Goto R., Mascie-Taylor C.G., Lunn P.G. Impact of intestinal permeability, inflammation status and parasitic infections on infant growth faltering in rural Bangladesh. Br J Nutr 2009, 101:1509-1516.
18. Campbell D.I., McPhail G., Lunn P.G., et al. Intestinal inflammation measured by fecal neopterin in Gambian children with enteropathy: association with growth failure, Giardia lamblia, and intestinal permeability. J Pediatr Gastroenterol Nutr 2004, 39:153-157.
19. Campbell D.I., Murch S.H., Lunn P.G., et al. Chronic T cell-mediated enteropathy in rural West African children: relationship with nutritional status and small bowel function. Pediatr Res 2003, 54:306-311.
20. Adams R.B., Planchon S.M., Roche J.K. IFNγ modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol 1993, 150:2356-2363.
21. Planchon S.M., Martins C.A., Guerrant R.L., Roche J.K. Regulation of intestinal epithelial barrier function by TGFβ1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol 1994, 153:5370-5379.
22. Barnes M.J., Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009, 31:401-411.
23. Kunkel E.J., Campbell D.J., Butcher E.C. Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation 2003, 10:313-323.
24. Zimmerman N.P., Vongsa R.A., Wendt M.K., Dwinell M.B. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:1000-1011.
25. Smith P.D., Ochsenbauer-Jambor C., Smythies L.E. Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev 2005, 206:149-159.
26. Sanderson I.R., Ouellette A.J., Carter E.A., et al. Differential regulation of B7 mRNA in enterocytes and lymphoid cells. Immunology 1993, 79:434-438.
27. Byrne B., Madrigal-Estebas L., McEvoy A., et al. Human duodenal epithelial cells constitutively express molecular components of antigen presentation but not costimulatory molecules. Hum Immunol 2002, 63:977-986.
28. Macpherson A.J., Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303:1662-1665.
29. Macpherson A.J., Smith K. Mesenteric lymph nodes at the center of immune anatomy. J Exp Med 2006, 203:497-500.
30. Berin M.C., Kiliaan A.J., Yang P.C., et al. Rapid transepithelial antigen transport in rat jejunum: impact of sensitization and the hypersensitivity reaction. Gastroenterology 1997, 113:856-864.
31. Yang P.C., Berin M.C., Yu L.C., et al. Enhanced intestinal transepithelial antigen transport in allergic rats is mediated by IgE and CD23 (FcεRII). J Clin Invest 2000, 106:879-886.
32. Izcue A., Coombes J.L., Powrie F. Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 2009, 27:313-338.
33. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
34. Bennett C.L., Christie J., Ramsdell F., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20-21.
35. Murch S. Advances in the understanding and management of autoimmune enteropathy. Current Paediatrics 2006, 16:305-316.
36. Cong Y., Feng T., Fujihashi K., et al. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci USA 2009, 106:19256-19261.
37. Wang Q., McLoughlin R.M., Cobb B.A., et al. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med 2006, 203:2853-2863.
38. Sudo N., Sawamura S., Tanaka K., et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997, 159:1739-1745.
39. Murch S.H. Toll of allergy reduced by probiotics. Lancet 2001, 357:1057-1059.
40. Bedford Russell A.R., Murch S.H. Could peripartum antibiotics have delayed health consequences for the infant?. Br J Obstetr Gynaecol 2006, 113:758-765.
41. Ishikawa H., Tanaka K., Maeda Y., et al. Effect of intestinal microbiota on the induction of regulatory CD25+ CD4+ T cells. Clin Exp Immunol 2008, 153:127-135.
42. Talham G.L., Jiang H.Q., Bos N.A., Cebra J.J. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect Immun 1999, 67:1992-2000.
43. Ivanov I.I., Atarashi K., Manel N., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
44. Gaboriau-Routhiau V., Rakotobe S., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31:677-689.
45. Adorini L. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann N Y Acad Sci 2003, 987:258-261.
46. Finamore A., Roselli M., Merendino N., et al. Zinc deficiency suppresses the development of oral tolerance in rats. J Nutr 2003, 133:191-198.
47. Strober W. Vitamin A rewrites the ABCs of oral tolerance. Mucosal Immunol 2008, 1:92-95.
48. Kang S.G., Wang C., Matsumoto S., Kim C.H. High and low vitamin A therapies induce distinct FoxP3+ T-cell subsets and effectively control intestinal inflammation. Gastroenterology 2009, 137:1391-1402.
49. Swartz-Basile D.A., Wang L., Tang Y., et al. Vitamin A deficiency inhibits intestinal adaptation by modulating apoptosis, proliferation, and enterocyte migration. Am J Physiol Gastrointest Liver Physiol 2003, 285:G424-G432.
50. Dong P., Tao Y., Yang Y., Wang W. Expression of retinoic acid receptors in intestinal mucosa and the effect of vitamin A on mucosal immunity. Nutrition 2010;26, 740-745.
51. Mora J.R., Iwata M., Eksteen B., et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006, 314:1157-1160.
52. Finkelman F.D., Holmes J., Katona I.M., et al. Lymphokine control of in vivo immunoglobulin isotype selection. Ann Rev Immunol 1990, 8:303-333.
53. Hayday A., Theodoridis E., Ramsburg E., Shires J. Intraepithelial lymphocytes: exploring the Third Way in immunology. Nat Immunol 2001, 2:997-1003.
54. Corr S.C., Gahan C.C., Hill C. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol Med Microbiol 2008, 52:2-12.
55. Matsushita M., Uchida K., Okazaki K. Role of the appendix in the pathogenesis of ulcerative colitis. Inflammopharmacology 2007, 15:154-157.
56. Mizoguchi A., Mizoguchi E., Chiba C., Bhan A.K. Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J Exp Med 1996, 184:707-715.
57. Smith H.F., Fisher R.E., Everett M.L., et al. Comparative anatomy and phylogenetic distribution of the mammalian cecal appendix. J Evol Biol 2009, 22:1984-1999.
58. Bollinger R.R., Barbas A.S., Bush E.L., et al. Biofilms in the large bowel suggest an apparent function of the human vermiform appendix. J Theor Biol 2007, 249:826-831.
59. Swidsinski A., Loening-Baucke V., Theissig F., et al. Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 2007, 56:343-350.
60. Gebbers J.O., Laissue J.A. Bacterial translocation in the normal human appendix parallels the development of the local immune system. Ann N Y Acad Sci 2004, 1029:337-343.
61. Mukherjee S., Vaishnava S., Hooper L.V. Multi-layered regulation of intestinal antimicrobial defense. Cell Mol Life Sci 2008, 65:3019-3027.
62. Bourbon J.R., Chailley-Heu B. Surfactant proteins in the digestive tract, mesentery, and other organs: evolutionary significance. Comp Biochem Physiol A Mol Integr Physiol 2001, 129:151-161.
63. Rossi M., Young J.W. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol 2005, 175:1373-1381.
64. Bland P.W., Kambarage D.M. Antigen handling by the epithelium and lamina propria macrophages. Gastroenterol Clin North Am 1991, 20:577-596.
65. + bacteria by M cells initiates mucosal immune response. Nature 2009, 462:226-230.
66. Rescigno M., Urbano M., Valzasina B., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2:361-367.
67. Niess J.H., Reinecker H.C. Dendritic cells in the recognition of intestinal microbiota. Cell Microbiol 2006, 8:558-564.
68. Baker K., Qiao S.W., Kuo T., et al. Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn. Semin Immunopathol 2009, 31:223-236.
69. Strober W. The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity 2009, 31:377-388.
70. Jaensson E., Uronen-Hansson H., Pabst O., et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 2008, 205:2139-2149.
71. Iliev I.D., Spadoni I., Mileti E., et al. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 2009, 58:1481-1489.
72. Josefowicz S.Z., Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009, 30:616-625.
73. Shevach E.M. Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
74. Murch S.H. Local and systemic effects of macrophage cytokines in intestinal inflammation. Nutrition 1998, 14:780-783.
75. Platt A.M., Mowat A.M. Mucosal macrophages and the regulation of immune responses in the intestine. Immunol Lett 2008, 119:22-31.
76. Grimm M.C., Pavli P., Doe W.F. Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa - implications for pathogenesis. Clin Exp Immunol 1995, 100:291-297.
77. Schenk M., Mueller C. Adaptations of intestinal macrophages to an antigen-rich environment. Semin Immunol 2007, 19:84-93.
78. Harrington L., Srikanth C.V., Antony R., et al. Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitis. Infect Immun 2008, 76:3045-3053.
79. Unutmaz D., Pulendran B. The gut feeling of Treg cells: IL-10 is the silver lining during colitis. Nat Immunol 2009, 10:1141-1143.
80. Kamada N., Hisamatsu T., Okamoto S., et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFNγ axis. J Clin Invest 2008, 118:2269-2280.
81. Kamada N., Hisamatsu T., Honda H., et al. Human CD14+ macrophages in intestinal lamina propria exhibit potent antigen-presenting ability. J Immunol 2009, 183:1724-1731.
82. Jung H.C., Eckmann L., Yang S.K., et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995, 95:55-65.
83. Chin A.C., Parkos C.A. Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking. Ann N Y Acad Sci. 2006, 1072:276-287.
84. MacDonald T.T., Murch S.H. The aetiology and pathogenesis of chronic inflammatory bowel disease. Baillière's Clin Gastroenterol 1994, 8:1-34.
85. Harbord M.W., Marks D.J., Forbes A., et al. Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor. Aliment Pharmacol Ther 2006, 24:651-660.
86. Voehringer D. The role of basophils in helminth infection. Trends Parasitol 2009, 25:551-556.
87. Fulkerson P.C., Rothenberg M.E. Origin, regulation and physiological function of intestinal eosinophils. Best Pract Res Clin Gastroenterol 2008, 22:411-423.
88. Yu L.C., Perdue M.H. Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress. Immunol Rev 2001, 179:61-73.
89. Khan W.I., Collins S.M. Gut motor function: immunological control in enteric infection and inflammation. Clin Exp Immunol 2006, 143:389-397.
90. Bischoff S.C. Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol 2009, 31:185-205.
91. Murch S. Allergy and intestinal dysmotility-evidence of genuine causal linkage?. Curr Opin Gastroenterol 2006, 22:664-668.
92. De Brosse C.W., Rothenberg M.E. Allergy and eosinophil-associated gastrointestinal disorders (EGID). Curr Opin Immunol 2008, 20:703-708.
93. Yan B.M., Shaffer E.A. Primary eosinophilic disorders of the gastrointestinal tract. Gut 2009, 58:721-732.
94. Guarner F., Bourdet-Sicard R., Brandtzaeg P., et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 2006, 3:275-284.
95. Kronenberg M., Kinjo Y. Innate-like recognition of microbes by invariant natural killer T cells. Curr Opin Immunol 2009, 21:391-396.
96. Agea E., Russano A., Bistoni O., et al. Human CD1-restricted T cell recognition of lipids from pollens. J Exp Med 2005, 202:295-308.
97. Morriset M., Lee T., Codreanu F., et al. Allergy to amino acid formula in infants: residual soy allergens in soybean oil are incriminated. J Allergy Clin Immunol 2006, 117:40.
98. Nanno M., Shiohara T., Yamamoto H., Kawakami K., Ishikawa H. γδ T cells: firefighters or fire boosters in the front lines of inflammatory responses. Immunol Rev 2007, 215:103-113.
99. Inagaki-Ohara K., Chinen T., Matsuzaki G., et al. Mucosal T cells bearing TCRγδ play a protective role in intestinal inflammation. J Immunol 2004, 173:1390-1398.
100. Kroese F.G.M., de Waard R., Bos N.A. B-1 cells and their reactivity with the murine intestinal microflora. Semin Immunol 1996, 8:11-18.
101. Fagarasan S., Kinoshita K., Muramatsu M., et al. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 2001, 413:639-643.
102. Lamm M.E., Phillips-Quagliata J.M. Origin and homing of intestinal IgA antibody-secreting cells. J Exp Med 2002, 195:F5-F8.
103. Woof J.M., Mestecky J. Mucosal immunoglobulins. Immunol Rev 2005, 206:64-82.
104. Kaetzel C.S. The polymeric immunoglobulin receptor: bridging innate and adaptive immunity at mucosal surfaces. Immunol Rev 2005, 206:83-99.
105. Klemola T., Savilahti E., Arato A., et al. Immunohistochemical findings in jejunal specimens from patients with IgA deficiency. Gut 1995, 37:519-523.
106. Zhou L., Chong M.M., Littman D.R. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009, 30:646-655.
107. Sallusto F., Lenig D., Förster R., et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
108. Masopust D., Jiang J., Shen H., Lefrançois L. Direct analysis of the dynamics of the intestinal mucosa CD8 T cell response to systemic virus infection. J Immunol 2001, 166:2348-2356.
109. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009, 58:1152-1167.
110. Maloy K.J. The interleukin-23/interleukin-17 axis in intestinal inflammation. J Intern Med 2008, 263:584-590.
111. Ivanov I.I., Frutos R., de L., Manel N., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
112. H17 cell differentiation. Nature 2008, 455:808-812.
113. Sakaguchi S., Sakaguchi N., Asano M., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
114. Faria A.M., Weiner H.L. Oral tolerance. Immunol Rev 2005, 206:232-259.
115. Murch S. Diabetes and cows' milk. Lancet 1996, 348:1656.
116. Miller A., Lider O., Abramsky O., Weiner H.L. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals. Eur J Immunol 1994, 24:1026-1032.
117. Latcham F., Merino F., Winter C., et al. A consistent pattern of minor immunodeficiency and subtle enteropathy in children with multiple food allergy. J Pediatr 2003, 143:39-47.
118. Hill D.J., Murch S.H., Rafferty K., et al. The efficacy of amino acid-based formulas in relieving the symptoms of cow's milk allergy: a systematic review. Clin Exp Allergy 2007, 37:808-822.
119. Pérez-Machado M.A., Ashwood P., Thomson M.A., et al. Reduced transforming growth factorβ1-producing T cells in the duodenal mucosa of children with food allergy. Eur J Immunol 2003, 33:2307-2315.
120. Karlsson M.R., Rugtveit J., Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004, 199:1679-1688.
121. Longo G., Barbi E., Berti I., et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 2008, 121:343-347.
122. Lotz M., Gütle D., Walther S., et al. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 2006, 203:973-984.
123. Protonotariou E., Malamitsi-Puchner A., Giannaki G., et al. Patterns of inflammatory cytokine serum concentrations during the perinatal period. Early Hum Dev 1999, 56:31-38.
124. Molberg O., Nilsen E.M., Sollid L.M., et al. CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology 1998, 114:115-122.
125. Lu J., Wang A., Ansari S., et al. Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis. Gastroenterology 2003, 125:1785-1795.
126. Shiobara N., Suzuki Y., Aoki H., et al. Bacterial superantigens and T cell receptor β-chain-bearing T cells in the immunopathogenesis of ulcerative colitis. Clin Exp Immunol 2007, 150:13-21.
127. Mashimo H., Wu D.C., Podolsky D.K., Fishman M.C. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996, 274:262-265.
128. Rothenberg M.E. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004, 113:11-28.
129. Blanchard C., Rothenberg M.E. Biology of the eosinophil. Adv Immunol 2009, 101:81-121.
130. Nienartowicz A., SobaniecŁotowska M.E., Jarocka-Cyrta E., Lemancewicz D. Mast cells in neoangiogenesis. Med Sci Monit 2006 Mar, 12:A53-A56.
131. Linfert D., Chowdhry T., Rabb H. Lymphocytes and ischemia-reperfusion injury. Transplant Rev 2009, 23:1-10.
132. Sekido N., Mukaida N., Harada A., et al. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 1993, 365:654-657.
133. Brogan P.A., Malik M., Shah N., et al. Systemic vasculitis: a cause of indeterminate intestinal inflammation. J Pediatr Gastroenterol Nutr 2006, 42:405-415.
134. Cameron H.L., Perdue M.H. Muscarinic acetylcholine receptor activation increases transcellular transport of macromolecules across mouse and human intestinal epithelium in vitro. Neurogastroenterol Motil 2007, 19:47-56.
135. Cameron H.L., Perdue M.H. Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2. J Pharmacol Exp Ther 2005, 314:214-220.
136. Straub R.H., Grum F., Strauch U., et al. Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation. Gut 2008, 57:911-921.
137. Bush T.G., Savidge T.C., Freeman T.C., et al. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 1998, 93:189-201.
138. Cornet A., Savidge T.C., Cabarrocas J., et al. Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease?. Proc Natl Acad Sci USA 2001, 98:13306-13311.
139. Savidge T.C., Newman P., Pothoulakis C., et al. Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology 2007, 132:1344-1358.
140. Greco L. From the neolithic revolution to gluten intolerance: benefits and problems associated with the cultivation of wheat. J Pediatr Gastroenterol Nutr 1997, 24:S14-S16.
141. Emanuel M.B. Hay fever, a post industrial revolution epidemic: a history of its growth during the 19th century. Clin Allergy 1988, 18:295-304.
142. Bostock J. Case of a periodical affliction of the eyes and the chest. Medico-Chirurg Transact 1819, 10:161-165.
143. Turner J.R. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009, 9:799-809.
144. Duerkop B.A., Vaishnava S., Hooper L.V. Immune responses to the microbiota at the intestinal mucosal surface. Immunity 2009, 31:368-376.
145. Barnes M.J., Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009, 31:401-411.
146. Izcue A., Coombes J.L., Powrie F. Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 2009, 27:313-338.
147. Strober W. The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity 2009, 31:377-388.
148. De Brosse C.W., Rothenberg M.E. Allergy and eosinophil-associated gastrointestinal disorders (EGID). Curr Opin Immunol 2008, 20:703-708.
149. See expertconsult.com for a complete list of references and the review questions for this chapter.